Latest Strategy News

Nyrada Inc. has announced successful Phase I trial results for its lead drug candidate Xolatryp, confirming safety and pharmacokinetics that pave the way for a Phase IIa trial targeting heart attack patients next year.

Island Pharmaceuticals has submitted a detailed briefing to the FDA aiming to accelerate approval of its antiviral Galidesivir for Marburg virus under the Animal Rule, with feedback expected by November.

Elixir Energy has commenced drilling the Diona-1 conventional gas-oil exploration well in Queensland’s Surat-Bowen Basin, aiming to unlock new production potential and secure long-term asset retention.

Dynamic Metals Limited has identified a significant gold-in-soil anomaly at its Courvoisier prospect within the Widgiemooltha Project, signalling promising potential for bedrock-hosted gold mineralisation. Meanwhile, assay results from recent drilling at Chalice South are eagerly awaited.

Broken Hill Mines has completed underground access to the high-grade Main Lode ore body at its Rasp Mine, delivering exceptional drilling results and targeting first ore extraction by November 2025.

EMVision Medical Devices launches a $2 million Share Purchase Plan offering shares at a 16.4% discount, bundled with free options exercisable at $3.40, aiming to bolster clinical and commercial milestones.

Terrain Minerals has reported robust high-grade gold intersections from its latest drilling at the Lightning prospect within the Smokebush Project, reinforcing the potential for a significant new gold system in Western Australia.

S2 Resources has significantly expanded its Jillewarra project area over a highly prospective gold shear zone and completed drilling at West Murchison, with assay results pending. Meanwhile, Glenlogan assays returned no significant mineralisation.

Rent.com.au reports strong early success with its RentBond® loan product, doubling loan volumes in September and drawing down a second $1 million tranche from its $10 million funding facility with Eldium.

Synlait Milk Limited reported an 11.7% rise in revenue to NZD 1.83 billion for the year ending July 2025, yet its net loss deepened sharply to nearly NZD 40 million, prompting a halt on dividends.

Gold Road Resources Limited shares have been suspended from the ASX following court approval of its acquisition by Gruyere Holdings Pty Ltd, marking a pivotal step in the gold miner’s corporate journey.

Venari Minerals has completed a $4.1 million placement, bolstering its efforts to advance key lithium and gold projects, including a maiden resource estimate at Red Mountain.